Literature DB >> 16791010

HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors.

Eva Poveda, Verónica Briz, Miguel Quiñones-Mateu, Vincent Soriano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16791010     DOI： 10.1097/01.aids.0000233569.74769.69

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  28 in total

1.  Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences: Therapeutic implications for India.

Authors:  Ujjwal Neogi; Sreenivasa B Prarthana; George D'Souza; Ayesha Decosta; Vijesh S Kuttiatt; Udaykumar Ranga; Anita Shet
Journal:  AIDS Res Ther       Date:  2010-07-21       Impact factor: 2.250

Review 2.  HIV-1 drug resistance mutations: an updated framework for the second decade of HAART.

Authors:  Robert W Shafer; Jonathan M Schapiro
Journal:  AIDS Rev       Date:  2008 Apr-Jun       Impact factor: 2.500

3.  High glucose enhances HIV entry into T cells through upregulation of CXCR4.

Authors:  Xiqian Lan; Kang Cheng; Nirupama Chandel; Rivka Lederman; Aakash Jhaveri; Mohammad Husain; Ashwani Malhotra; Pravin C Singhal
Journal:  J Leukoc Biol       Date:  2013-08-02       Impact factor: 4.962

4.  Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase.

Authors:  Bryan D Cox; Anthony R Prosser; Yongnian Sun; Zhufang Li; Sangil Lee; Ming B Huang; Vincent C Bond; James P Snyder; Mark Krystal; Lawrence J Wilson; Dennis C Liotta
Journal:  ACS Med Chem Lett       Date:  2015-05-06       Impact factor: 4.345

5.  Canadian consensus guidelines for the optimal use of maraviroc in the treatment of HIV-infected adults.

Authors:  Anita Rachlis; Marianne Harris; Richard Lalonde; Stephen D Shafran; Cécile Tremblay; Mark A Wainberg; Sharon Walmsley
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

6.  Next-Generation Sequencing to Help Monitor Patients Infected with HIV: Ready for Clinical Use?

Authors:  Richard M Gibson; Christine L Schmotzer; Miguel E Quiñones-Mateu
Journal:  Curr Infect Dis Rep       Date:  2014-04       Impact factor: 3.725

7.  HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays.

Authors:  Ina Vandenbroucke; Herwig Van Marck; Wendy Mostmans; Veerle Van Eygen; Evelien Rondelez; Kim Thys; Kurt Van Baelen; Katrien Fransen; Dolores Vaira; Kabamba Kabeya; Stephane De Wit; Eric Florence; Michel Moutschen; Linos Vandekerckhove; Chris Verhofstede; Lieven J Stuyver
Journal:  AIDS Res Ther       Date:  2010-02-15       Impact factor: 2.250

8.  Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.

Authors:  Jan Weber; Ana C Vazquez; Dane Winner; Richard M Gibson; Ariel M Rhea; Justine D Rose; Doug Wylie; Kenneth Henry; Alison Wright; Kevin King; John Archer; Eva Poveda; Vicente Soriano; David L Robertson; Paul D Olivo; Eric J Arts; Miguel E Quiñones-Mateu
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948

Review 9.  Deep sequencing: becoming a critical tool in clinical virology.

Authors:  Miguel E Quiñones-Mateu; Santiago Avila; Gustavo Reyes-Teran; Miguel A Martinez
Journal:  J Clin Virol       Date:  2014-06-24       Impact factor: 3.168

10.  Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc.

Authors:  Olga Latinovic; Janaki Kuruppu; Charles Davis; Nhut Le; Alonso Heredia
Journal:  Clin Med Ther       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.